Immune Clinical Trials in Beijing, Beijing Municipality
34 recruitingBeijing, Beijing Municipality, China
Showing 1–20 of 34 trials
Recruiting
Phase 3
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Takeda150 enrolled108 locationsNCT06948318
Recruiting
Phase 2
Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
Lung CancerRadiotherapyImmune Checkpoint Inhibitor+1 more
Tianjin Medical University Cancer Institute and Hospital30 enrolled3 locationsNCT07058948
Recruiting
Phase 1Phase 2
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital30 enrolled1 locationNCT07464132
Recruiting
Phase 1Phase 2
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Autoimmune Diseases
Beijing GoBroad Hospital18 enrolled1 locationNCT06688799
Recruiting
Phase 2
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
B-cell Mediated Autoimmune DisordersIgG4-related Disease
Chinese PLA General Hospital9 enrolled1 locationNCT07148791
Recruiting
Phase 2
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
Immune Thrombocytopenia (ITP)
Peking University People's Hospital132 enrolled3 locationsNCT07065968
Recruiting
Phase 1
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd.12 enrolled1 locationNCT06826430
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients
PD-1Immune-related Adverse Events
Guohui Li100 enrolled1 locationNCT04840355
Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
ThrombophiliaThrombosisArterial Thromboembolism+13 more
Peking University People's Hospital3,000 enrolled5 locationsNCT06727669
Recruiting
Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Autoimmune Pancreatitis
Peking Union Medical College Hospital180 enrolled1 locationNCT06369909
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Systemic Lupus ErythematosusSjogren's SyndromeAutoimmune Diseases+1 more
Essen Biotech60 enrolled1 locationNCT06428188
Recruiting
Phase 1Phase 2
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisSjogren's Syndrome+6 more
Essen Biotech75 enrolled1 locationNCT06350110
Recruiting
Not Applicable
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
CDK4/6 InhibitorChemotherapeutic ToxicityTrastuzumab+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences148 enrolled1 locationNCT06197581
Recruiting
National, Multicentric Registry Study on Neuroimmunological Diseases in China
Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Xuanwu Hospital, Beijing7,000 enrolled1 locationNCT06443333
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital20,000 enrolled9 locationsNCT06417502
Recruiting
Phase 2
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
Warm Autoimmune Hemolytic Anemia
Chen Miao22 enrolled1 locationNCT05922839
Recruiting
Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease
MicrobiomeImmune FunctionAnti-MDA5 Antibody Positive Dermatomyositis
Chinese PLA General Hospital50 enrolled1 locationNCT06203249
Recruiting
China National Registry of Neuro-Inflammatory Diseases
Multiple SclerosisClinically Isolated SyndromeAcute Disseminated Encephalomyelitis+4 more
Beijing Tiantan Hospital10,000 enrolled1 locationNCT05154370
Recruiting
Phase 2
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Cervical CarcinomaImmunotherapyImmune Checkpoint Inhibitor+6 more
Lei Li92 enrolled1 locationNCT05311566